Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts:: a mechanism for tissue-specific regulation of inflammation

被引:76
|
作者
Hardy, Rowan S.
Filer, Andrew
Cooper, Mark S.
Parsonage, Greg
Raza, Karim
Hardie, Debbie L.
Rabbitt, Elizabeth H.
Stewart, Paul M.
Buckley, Christopher D.
Hewison, Martin [1 ]
机构
[1] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA
[2] Univ Birmingham, Sch Med, Div Med Sci, Inst Biomed Res, Birmingham, W Midlands, England
[3] Univ Birmingham, Sch Med, Div Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England
基金
英国医学研究理事会;
关键词
D O I
10.1186/ar1993
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stromal cells such as fibroblasts play an important role in defining tissue-specific responses during the resolution of inflammation. We hypothesized that this involves tissue-specific regulation of glucocorticoids, mediated via differential regulation of the enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1). Expression, activity and function of 11 beta-HSD1 was assessed in matched fibroblasts derived from various tissues (synovium, bone marrow and skin) obtained from patients with rheumatoid arthritis or osteoarthritis. 11 beta-HSD1 was expressed in fibroblasts from all tissues but mRNA levels and enzyme activity were higher in synovial fibroblasts (2-fold and 13-fold higher mRNA levels in dermal and synovial fibroblasts, respectively, relative to bone marrow). Expression and activity of the enzyme increased in all fibroblasts following treatment with tumour necrosis factor-alpha or IL-1 beta (bone marrow: 8-fold and 37-fold, respectively, compared to vehicle; dermal fibroblasts: 4-fold and 14-fold; synovial fibroblasts: 7-fold and 31-fold; all P < 0.01 compared with vehicle). Treatment with IL-4 or interferon-gamma was without effect, and there was no difference in 11 beta-HSD1 expression between fibroblasts (from any site) obtained from patients with rheumatoid arthritis or osteoarthritis. In the presence of 100 nmol/l cortisone, IL-6 production - a characteristic feature of synovial derived fibroblasts - was significantly reduced in synovial but not dermal or bone marrow fibroblasts. This was prevented by co-treatment with an 11 beta-HSD inhibitor, emphasizing the potential for autocrine activation of glucocorticoids in synovial fibroblasts. These data indicate that differences in fibroblast-derived glucocorticoid production (via the enzyme 11 beta-HSD1) between cells from distinct anatomical locations may play a key role in the predeliction of certain tissues to develop persistent inflammation.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] DEPOT-SPECIFIC REGULATION OF 11B-HYDROXYSTEROID DEHYDROGENASE TYPE 1 EXPRESSION IN ADIPOSE TISSUE OF CHILDREN BY STEROIDS HORMONES
    Li, X.
    Zhu, L.
    Zhang, L.
    Yi, J.
    Sun, B.
    Buren, J.
    Hernell, O.
    [J]. ACTA PAEDIATRICA, 2009, 98 : 37 - 37
  • [22] Induction of 11β-hydroxysteroid dehydrogenase type 1 but not-2 in human aortic smooth muscle cells by inflammatory stimuli
    Cai, TQ
    Wong, BM
    Mundt, SS
    Thieringer, R
    Wright, SD
    Hermanowski-Vosatka, A
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 77 (2-3): : 117 - 122
  • [23] Expression of 11β-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells
    Freeman, L
    Hewison, M
    Hughes, SV
    Evans, KN
    Hardie, D
    Means, TK
    Chakraverty, R
    [J]. BLOOD, 2005, 106 (06) : 2042 - 2049
  • [24] THE MURINE 3-BETA-HYDROXYSTEROID DEHYDROGENASE MULTIGENE FAMILY - STRUCTURE, FUNCTION AND TISSUE-SPECIFIC EXPRESSION
    PAYNE, AH
    CLARKE, TR
    BAIN, PA
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 53 (1-6): : 111 - 118
  • [25] Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome -: 11β-hydroxysteroid dehydrogenase type 1
    Stewart, PM
    [J]. CLINICAL MEDICINE, 2005, 5 (02) : 142 - 146
  • [26] Tissue-specific changes in peripheral cortisol metabolism in obese women:: Increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity
    Rask, E
    Walker, BR
    Söderberg, S
    Livingstone, DEW
    Eliasson, M
    Johnson, O
    Andrew, R
    Olsson, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (07): : 3330 - 3336
  • [27] Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Human Fetal Lung and Regulation of Its Expression by Interleukin-1β and Cortisol
    Yang, Zhen
    Zhu, Ping
    Guo, Chunming
    Zhu, Xiaoou
    Sun, Kang
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01): : 306 - 313
  • [28] TISSUE-SPECIFIC EFFECTS OF THYROID-HORMONE ON 11-BETA-HYDROXYSTEROID DEHYDROGENASE GENE-EXPRESSION
    WHORWOOD, CB
    SHEPPARD, MC
    STEWART, PM
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1993, 46 (05): : 539 - 547
  • [29] Synergistic induction of 11β-hydroxysteroid dehydrogenase type 1 expression by cortisol and interleukin-1β in human fetal lung fibroblasts
    Yang, Z.
    Guo, C. M.
    Myatt, L.
    Sun, K.
    [J]. PEDIATRIC RESEARCH, 2007, 62 (03) : 383 - 383
  • [30] Expression and regulation of 11β-hydroxysteroid dehydrogenase type 1 in first trimester human decidua cells: Implication in preeclampsia
    Funghi, Lucia
    Damiani, Francesco
    Yen, Chih-Feng
    Lee, Chyi-Long
    Lombardi, Annalia
    Schatz, Frederick
    Lockwood, Charles J.
    Marcolongo, Paola
    Petraglia, Felice
    Arcuri, Felice
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2016, 437 (0C) : 163 - 170